Literature DB >> 10099840

Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas.

W Li1, M Yanoff, B Jian, Z He.   

Abstract

Because programmed cell death (PCD) is an important mode of pericyte dropout in human diabetic retinopathy, whether increased oxidative stress in cells with diminished antioxidant defenses plays a causative role in the PCD process in diabetic pericytes has been studied. Ten diabetic and eight non-diabetic eye-bank eyes from 5 diabetic and 4 non-diabetic patients were included in this study. From individual neural retinas pericytes were isolated by a newly developed immunomagnetic technique. Total mRNA of the purified pericytes was isolated for quantitative reverse transcriptase (RT)-PCR assay. mRNA levels of a death protease (CPP32), the major enzyme that initiates the proteolytic cascade leading to cell death, were determined in association with the expression of antioxidative enzymes including glutathione peroxidase (GSH-Px), glutathione reductase, CuZn superoxide dismutase (SOD), MnSOD and catalase genes in pericytes. In comparison with pericytes from non-diabetic retinas, pericytes from diabetic retinas highly expressed CPP32 genes (4 +/- 0.6 fold increase, p < 0.01, n = 9). In diabetic pericytes, up-regulation of glutathione peroxidase (GSH-Px) (8.2 +/- 0.9 fold increase, p < 0.01, n = 9) and down-regulation of glutathione reductase (Gr) (4.1 +/- 0.4 fold decrease, p < 0.05, n = 9) and CuZnSOD (2.1 +/- 0.7 fold decrease, p < 0.05, n = 9) were observed. mRNA levels of MnSOD and catalase of diabetic pericytes did not differ significantly from those of non-diabetic pericytes. Overexpression of a member of interleukin-1 beta-converting enzyme (ICE) family, CPP32, indicated that the pericytes from diabetic retinas are in a "pre-PCD" state. This is the first evidence that the ICE family of death proteases is involved in pericyte dropout in diabetes. In these pre-PCD cells, the expression of antioxidant enzyme genes also was changed. Up-regulation of GSH-Px indicates a compensation mechanism to meet the demand of excessive glutathione in reduced form. Decreased levels of both glutathione reductase and CuZnSOD, despite the oxidative stress in the diabetic condition, suggest the breakdown of the antioxidant defense in pericytes. Most importantly, the altered gene profile of scavenging enzymes under diabetic conditions, correlating with overexpression of the cell death protease gene, together suggest increased oxidative stress as an etiological agent of pericyte dropout in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099840

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  16 in total

1.  A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.

Authors:  G Srividya; M Jain; K Mahalakshmi; S Gayathri; R Raman; N Angayarkanni
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  Regulation of extracellular-superoxide dismutase in rat retina pericytes.

Authors:  Tetsuo Adachi; Hiroyuki Yasuda; Kazunari Aida; Tetsuro Kamiya; Hirokazu Hara; Ken-ichi Hosoya; Tetsuya Terasaki; Tsunehiko Ikeda
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 3.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

4.  AGEs Promote Oxidative Stress and Induce Apoptosis in Retinal Pigmented Epithelium Cells RAGE-dependently.

Authors:  Xin-Ling Wang; Tao Yu; Qi-Chang Yan; Wei Wang; Nan Meng; Xue-Jiao Li; Ya-Hong Luo
Journal:  J Mol Neurosci       Date:  2015-02-15       Impact factor: 3.444

5.  Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Mohammad Mairaj Siddiquei
Journal:  J Ocul Biol Dis Infor       Date:  2012-07-06

Review 6.  Mitochondrial dysfunction in retinal diseases.

Authors:  Megha Barot; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Curr Eye Res       Date:  2011-10-06       Impact factor: 2.424

Review 7.  Diabetic retinopathy, superoxide damage and antioxidants.

Authors:  Julia M Santos; Ghulam Mohammad; Qing Zhong; Renu A Kowluru
Journal:  Curr Pharm Biotechnol       Date:  2011-03-01       Impact factor: 2.837

8.  Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.

Authors:  X Zhang; Y Lai; D R McCance; K Uchida; D M McDonald; T A Gardiner; A W Stitt; T M Curtis
Journal:  Diabetologia       Date:  2008-06-28       Impact factor: 10.122

Review 9.  Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

Authors:  Sally A Madsen-Bouterse; Renu A Kowluru
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

10.  Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina.

Authors:  Vibhuti Kowluru; Renu A Kowluru
Journal:  Mol Vis       Date:  2007-04-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.